• S13 E01 Small Company, Seismic Impact: KYE Pharmaceuticals Redefines ADHD Treatment

  • Oct 2 2024
  • Length: 36 mins
  • Podcast

S13 E01 Small Company, Seismic Impact: KYE Pharmaceuticals Redefines ADHD Treatment

Listen for free

View show details

  • Summary

  • John McKendry, President and CEO of KYE, gives insights into the importance of operating within regulations, leadership in pharma, and new treatment and delivery options for ADHD.



    Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
    Show More Show Less
Show More Show Less

What listeners say about S13 E01 Small Company, Seismic Impact: KYE Pharmaceuticals Redefines ADHD Treatment

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.